NCT03636542View on ClinicalTrials.gov

Evaluation of Diaphragm Movement After an Interscalene Block

PHASE4CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

August 1, 2018

Primary Completion Date

June 3, 2020

Study Completion Date

June 3, 2020

Conditions
Phrenic Nerve Paralysis
Interventions
DRUG

liposomal bupivacaine

Experimental

DRUG

bupivacaine

Active comparator

Trial Locations (1)

55455

Univeristy of Minnesota, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER

NCT03636542 - Evaluation of Diaphragm Movement After an Interscalene Block | Biotech Hunter | Biotech Hunter